Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125370331 | 12537033 | 1 | I | 2016 | 20160628 | 20160707 | 20160707 | EXP | US-009507513-1606USA013625 | MERCK | 68.00 | YR | F | Y | 75.00000 | KG | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125370331 | 12537033 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 40 MG, QD | Y | 19558 | 40 | MG | TABLET | QD | |||||
| 125370331 | 12537033 | 2 | SS | PRINIVIL | LISINOPRIL | 1 | Oral | 10 MG, QD | Y | 19558 | 10 | MG | TABLET | QD | |||||
| 125370331 | 12537033 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QD | 1120 | MG | Y | 0 | 40 | MG | TABLET | QD | |||
| 125370331 | 12537033 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | 1120 | MG | Y | 0 | 20 | MG | TABLET | QD | |||
| 125370331 | 12537033 | 5 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 25 MG, TID | 150 | MG | Y | 0 | 25 | MG | TID | ||||
| 125370331 | 12537033 | 6 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 25 MG, BID | 150 | MG | Y | 0 | 25 | MG | BID | ||||
| 125370331 | 12537033 | 7 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | 27000 | MG | Y | 0 | 500 | MG | BID | ||||
| 125370331 | 12537033 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 9 | C | HYDROXYCHLOROQUINE SULFATE. | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 10 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 11 | C | ULTRACET | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 12 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 13 | C | SENNA S (docusate sodium (+) sennosides) | 2 | UNK | U | 0 | TABLET | ||||||||||
| 125370331 | 12537033 | 14 | C | LEVEMIR | INSULIN DETEMIR | 1 | UNK | U | 0 | ||||||||||
| 125370331 | 12537033 | 15 | C | NOVOLOG | INSULIN ASPART | 1 | UNK | U | 0 | ||||||||||
| 125370331 | 12537033 | 16 | C | ASPIRIN. | ASPIRIN | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 17 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | UNK | U | 0 | INJECTION | |||||||||
| 125370331 | 12537033 | 18 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 19 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 20 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 21 | C | LOTRISONE | BETAMETHASONE DIPROPIONATECLOTRIMAZOLE | 1 | UNK | U | 0 | CREAM | |||||||||
| 125370331 | 12537033 | 22 | C | ISOSORBIDE. | ISOSORBIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 23 | C | SOTALOL. | SOTALOL | 1 | UNK | U | 0 | TABLET | |||||||||
| 125370331 | 12537033 | 24 | C | CLOBETASOL PROPIONATE. | CLOBETASOL PROPIONATE | 1 | UNK | U | 0 | CREAM | |||||||||
| 125370331 | 12537033 | 25 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | FORMULATION: TABLET | U | 0 | TRANSDERMAL PATCH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125370331 | 12537033 | 1 | Hypertension |
| 125370331 | 12537033 | 3 | Hypertension |
| 125370331 | 12537033 | 5 | Supraventricular tachycardia |
| 125370331 | 12537033 | 7 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125370331 | 12537033 | HO |
| 125370331 | 12537033 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125370331 | 12537033 | Acute kidney injury | |
| 125370331 | 12537033 | Diarrhoea | |
| 125370331 | 12537033 | Hypoglycaemia | |
| 125370331 | 12537033 | Urinary tract infection | |
| 125370331 | 12537033 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125370331 | 12537033 | 1 | 201601 | 20160429 | 0 | |
| 125370331 | 12537033 | 2 | 20160502 | 0 | ||
| 125370331 | 12537033 | 3 | 20160401 | 20160429 | 0 | |
| 125370331 | 12537033 | 4 | 20160502 | 0 | ||
| 125370331 | 12537033 | 5 | 20160427 | 20160429 | 0 | |
| 125370331 | 12537033 | 6 | 20160430 | 0 | ||
| 125370331 | 12537033 | 7 | 20160401 | 20160427 | 0 | |
| 125370331 | 12537033 | 8 | 2013 | 0 | ||
| 125370331 | 12537033 | 9 | 2011 | 0 | ||
| 125370331 | 12537033 | 10 | 2012 | 0 | ||
| 125370331 | 12537033 | 11 | 2000 | 0 | ||
| 125370331 | 12537033 | 12 | 2012 | 0 | ||
| 125370331 | 12537033 | 13 | 2014 | 0 | ||
| 125370331 | 12537033 | 14 | 20160317 | 20160430 | 0 | |
| 125370331 | 12537033 | 15 | 20160317 | 0 | ||
| 125370331 | 12537033 | 16 | 2012 | 0 | ||
| 125370331 | 12537033 | 17 | 2013 | 0 | ||
| 125370331 | 12537033 | 18 | 2011 | 0 | ||
| 125370331 | 12537033 | 19 | 2013 | 0 | ||
| 125370331 | 12537033 | 20 | 201512 | 0 | ||
| 125370331 | 12537033 | 21 | 2011 | 0 | ||
| 125370331 | 12537033 | 22 | 20160123 | 0 | ||
| 125370331 | 12537033 | 23 | 20160123 | 20160427 | 0 | |
| 125370331 | 12537033 | 24 | 20160401 | 0 | ||
| 125370331 | 12537033 | 25 | 2009 | 0 |